Shares of Merck KGaA (OTCMKTS:MKGAF – Get Free Report) were up 9.8% during trading on Tuesday . The company traded as high as $154.3540 and last traded at $154.3540. Approximately 10 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 462 shares. The stock had previously closed at $140.5340.
Merck KGaA Stock Down 2.2%
The business has a fifty day moving average of $146.97 and a 200-day moving average of $137.07. The stock has a market cap of $19.25 billion, a PE ratio of 22.74 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- BNZI: Triple-Digit Growth, Zacks Approved!
- They’ve Built Major Gold Stories Before – And They’re Doing It Again
- How to collect $500-$800 weekly (BlackRock’s system)
- Nvidia CEO Issues Bold Tesla Call
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
